Licentis Technical
Registered name: LICENTIS TECHNICAL
Part of Ip3 Technologies Incorporated groupLicentis Technical made £0 revenue and a £80.3k loss in the year to 28 Feb 2026.
Licentis Technical’s revenue was £0 in the year to 28 Feb 2026, with a loss of £80.3k and 2 employees. The company is classified under “research and experimental development on biotechnology” and is based in Cheltenham; we hold 5 years of its filed accounts.
- Status
- Active
- Location
- Cheltenham, South West
- Age
- 10 yrs · since 2016
- Type
- Private Unlimited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 30 Jun 2022 | 30 Jun 2023 | 30 Jun 2024 | 30 Jun 2025 | 28 Feb 2026 |
|---|---|---|---|---|---|
| Disclosure | No P&L | No P&L | No P&L | Full P&L | Full P&L |
| Profit & loss | |||||
| Revenue (turnover) | — | — | — | £0 | £0 |
| Cost of sales | — | — | — | −£1 | −£1 |
| Gross profit | — | — | — | £1 | £1 |
| Profit before tax | — | — | — | −£121k | −£88.4k |
| Profit after tax | — | — | — | −£105k | −£80.3k |
| Profit (best available) | — | — | — | −£105k | −£80.3k |
| Employees (average) | 3 | 3 | 2 | 2 | 2 |
| Ratios | |||||
| Profit margin | — | — | — | — | — |
| Revenue per employee | — | — | — | £0 | £0 |
| Profit per employee | — | — | — | −£52.7k | −£40.1k |
| Growth (year on year) | |||||
| Headcount growth | — | 0% | ▼33.3% | 0% | — |
| Balance sheet — indirect signals, not revenue | |||||
| Cash at bank | £13.7k | £1.4k | £590 | £483 | £6.3k |
| Net assets | £452k | £183k | £73.4k | £32.1k | −£112k |
| Fixed assets | £1.8m | £1.8m | £1.8m | £1.8m | £1.8m |
| Current assets | £22k | £44k | £63.4k | £16.8k | £30.7k |
| Debtors | £8.2k | £42.5k | £62.8k | £16.3k | £24.3k |
| Source | AbridgedAccounts · bulk data Mar 2024 | AbridgedAccounts · bulk data Mar 2024 | AbridgedAccounts · bulk data Feb 2025 | FullAccounts · bulk data Mar 2026 | FullAccounts · bulk data Jun 2026 |
How the business works
- Profit margin
- —
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £0
- Revenue ÷ average employees.
- Profit per employee
- −£40.1k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now −£112k
- Cash at bank
- —
- Now £6.3k
- Headcount
- —
- Now 2
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now £1.8m
Group structure
Ownership chain
- Ip3 Technologies Incorporated (registered outside the UK register)ultimate parent75–100%
- Licentis Technicalthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Astex Therapeutics LimitedCambridge · Research and experimental development on biotechnology
- Revenue
- £404m
- Profit
- £283m
- Staff
- 183
- Charles River U.K. LimitedKent · Research and experimental development on biotechnology
- Revenue
- £22.2m
- Profit
- £18.8m
- Staff
- 129
- Qiagen Manchester LimitedManchester · Research and experimental development on biotechnology
- Revenue
- £53.7m
- Profit
- £11.8m
- Staff
- 239
- Theradex (Europe) LimitedRedhill · Research and experimental development on biotechnology
- Revenue
- £15.2m
- Profit
- £3.1m
- Staff
- 43
- Novogene (UK) Company LimitedCambridge · Research and experimental development on biotechnology
- Revenue
- £38.2m
- Profit
- £2.8m
- Staff
- 68
- Askbio UK LtdMidlothian · Research and experimental development on biotechnology
- Revenue
- £12.5m
- Profit
- £1.8m
- Staff
- 54
Sources
Latest figures from FullAccounts for the year to 28 Feb 2026 (profit −£80.3k), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.